Engineers Gate Manager LP Sorrento Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $11,709 - $28,956	15,823 Added 20.39%	93,433 $83,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $105,885 - $201,954	-70,123 Reduced 47.47%	77,610 $122,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $51,898 - $97,519	41,854 Added 39.53%	147,733 $297,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $156,632 - $383,748	78,316 Added 284.13%	105,879 $247,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $128,167 - $199,280	27,563 New	27,563 $128,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $400,685 - $631,000	-63,100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $66,785 - $156,845	-9,500 Reduced 13.09%	63,100 $522,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $418,176 - $867,570	72,600 New	72,600 $495,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.